Assessment of AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer. Journal of Pharmaceutical Negative Results, [S. l.], p. 1103–1106, 2022. DOI: 10.47750/pnr.2022.13.S03.172. Disponível em: https://pnrjournal.com/index.php/home/article/view/815.. Acesso em: 5 jun. 2026.